Afya (AFYA) affiliate plans sale of 150,000 Class A shares on Nasdaq
Rhea-AI Filing Summary
Afya Limited files a Form 144 notice reporting a proposed sale of 150,000 Class A common shares with an aggregate value of $2,064,000.00, listed for sale through Itau International Securities Inc on 03/17/2026 on Nasdaq Global Select.
The filing also lists recent acquisitions that affect available holdings: 17,953 shares from a Restricted Share Units Program (05/01/2023), 38,027 shares from RSUs (05/01/2025), and 100,000 shares issued under a Stock Option Plan (S-8) (06/27/2025), plus an entry showing $2,064,000.00 aggregate and a separate date 06/09/2025 tied to a cash-related line item.
Positive
- None.
Negative
- None.
Insights
Form 144 registers an affiliate resale of 150,000 Class A shares valued at $2,064,000.00.
The notice names Itau International Securities Inc as the broker of record and lists the Nasdaq Global Select market with a filing date of 03/17/2026. The filing records prior acquisitions: 17,953 and 38,027 RSU shares and 100,000 shares from an S-8 issuance, which help explain the holder's source of saleable shares.
Cash‑flow treatment for proceeds is not detailed beyond the aggregate value line; subsequent public disclosures or broker reports would show execution method and timing. Monitoring future filings will show whether the resale is completed.
The filing documents an affiliate resale notice and traces recent equity grants that supplied the shares.
The entries for restricted share unit grants on 05/01/2023 and 05/01/2025, plus the S-8 issuance on 06/27/2025, indicate the saleable shares originated from compensation plans and option exercises. These lines are labeled as equity compensation and stock option plan receipts.
Because the Form 144 is a notice of intent to sell, actual market impact depends on execution; the filing lists quantities and acquisition dates but does not specify sale mechanics beyond the broker and market.
FAQ
What amount of Afya (AFYA) stock is the Form 144 proposing to sell?
Who is listed as the broker for the proposed AFYA share sale?
What recent equity grants or issuances increased the seller's AFYA holdings?
Does the Form 144 state who will receive the sale proceeds?
Are the listed acquisitions tied to compensation plans or other programs?